Stocklytics Platform
Asset logo for symbol AMED
Amedisys
AMED49
$95.49arrow_drop_up0.94%$0.89
Asset logo for symbol AMED
AMED49

$95.49

arrow_drop_up0.94%

AI Deep-Learning Forecast (AMED)

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

Amedisys (AMED) Stocklytics Forecast

Amedisys Inc (AMED) is a leading healthcare services company that specializes in providing home health, hospice, and personal care services. The company has a strong track record of growth and profitability, making it an attractive investment opportunity for investors. With a focus on delivering high-quality care to patients in the comfort of their own homes, Amedisys has positioned itself as a leader in the home healthcare industry. The company has a diverse portfolio of services that cater to the needs of patients of all ages and medical conditions. With an aging population and increasing demand for healthcare services, Amedisys is well-positioned to capitalize on these trends and drive future growth.
In terms of its stock price, Amedisys has shown strong performance in recent years. The stock has consistently outperformed the broader market, delivering significant returns to shareholders. Over the past five years, Amedisys stock has more than doubled in value, demonstrating its ability to generate long-term value for investors. Looking ahead, analysts expect Amedisys to continue its growth trajectory. The company is projected to achieve double-digit revenue growth and expand its market share in the coming years. This positive outlook is driven by several factors, including a favorable regulatory environment, increasing patient demand for home healthcare services, and Amedisys' strategic initiatives to drive operational efficiencies and improve patient outcomes.
add Amedisys  to watchlist

Keep an eye on Amedisys

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is the analyst price prediction for Amedisys (AMED) stock?

Analysts have set a target price of $103.68 for Amedisys (AMED), based on forecasts from 22 analysts. The predicted price range extends from a high of $120 to a low of $84. This represents a potential increase of up to 25.67% and a decrease of -12.03% from the current price of $95.49. These forecasts are as of 2023 Jan 23.
help

What are the analyst ratings for Amedisys (AMED) stock?

Currently, there are no analyst ratings available for Amedisys (AMED), possibly due to insufficient coverage or recent updates.
help

What is the AI price prediction for Amedisys (AMED) stock?

At present, there is no AI or machine-learning-based price prediction available for Amedisys (AMED) stock. The lack of a forecast could stem from various factors, such as inadequate data or the necessity for model recalibration.

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level